Skip to product information
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Research has shown it to produce significant reductions in body weight and improvements in metabolic markers. The 10MG injectable formulation provides a research-grade supply for studying this novel multi-receptor approach to metabolic health.
Key Benefits:
• Triple receptor activation
• Significant weight reduction
• Improved metabolic markers
• Blood sugar regulation
• Cardiovascular risk factor reduction
Retatrutide 10MG INJ
$350.00
Sale price
$350.00
Regular price
Key Benefits:
• Triple receptor activation
• Significant weight reduction
• Improved metabolic markers
• Blood sugar regulation
• Cardiovascular risk factor reduction